Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial of Hyperthermia in Combination With Olaparib in Breast Cancer Patients With Chest Wall Recurrences

NCT03955640 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT03955640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03955640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial of Hyperthermia in Combination With Olaparib in Breast Cancer Patients With Chest Wall Recurrences
Lead sponsor
Thomas Jefferson University
Phase
Phase 1
Overall status
Terminated
Start date
May 20, 2019
Completion date
August 26, 2021
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant neoplasm in the chest wall, recurrent breast carcinoma